Assessment of Neurocognitive Functions, Olfaction, Taste, Mental, and Psychosocial Health in COVID-19 in Adults: Recommendations for Harmonization of Research and Implications for Clinical Practice.

Assessment of Neurocognitive Functions, Olfaction, Taste, Mental, and Psychosocial Health in COVID-19 in Adults: Recommendations for Harmonization of Research and Implications for Clinical Practice.
复制标题

DOI:
10.1017/s1355617721000862
复制
发表时间:
2022-07
期刊:
Journal of the International Neuropsychological Society : JINS
影响因子:
--
通讯作者:
NeuroCOVID International Neuropsychology Taskforce
NeuroCOVID International Neuropsychology Taskforce
中科院分区:
其他
文献类型:
--
作者:
Cysique LA;Łojek E;Cheung TC;Cullen B;Egbert AR;Evans J;Garolera M;Gawron N;Gouse H;Hansen K;Holas P;Hyniewska S;Malinowska E;Marcopulos BA;Merkley TL;Muñoz-Moreno JA;Ramsden C;Salas C;Sikkes SAM;Silva AR;Zouhar I;NeuroCOVID International Neuropsychology Taskforce

文献摘要

被引文献

相似文献

提出一套国际统一的程序和方法,用于评估正式诊断为COVID-19(确诊的SARS-CoV-2+世卫组织定义)的成年人的神经认知功能、嗅觉、味觉、精神和心理健康以及其他因素。2020年4月,我们成立了一个国际跨学科神经心理学工作组。七个标准用于指导建议方法和程序的选择:(i)与所有COVID-19疾病阶段和纵向研究设计的相关性;标准的、跨文化有效的或广泛可得的工具;(三)涵盖与COVID-19相关的神经和精神症状的直接和间接原因;(四)控制可能影响神经心理表现的与COVID-19特别相关的因素;㈤管理灵活性(远程保健、计算机化、远程/在线、面对面);协调促进国际研究;(vii)易于转化为临床实践。拟议的三个协调级别包括具有远程保健选项的筛查战略、具有在线/远程选项的中等规模计算机化评估以及具有灵活管理的综合评估。描述了可能使用每个协调级别的上下文。还描述了评估时间表、支持数据保真和远程保健考虑的家庭/远程评估指南、跨文化充分性、规范和损害定义等问题。提出的建议为COVID-19成人神经心理学研究和临床评估提供了基本原理和方法指导。我们期望这些建议的使用将促进数据统一和全球研究。实施这些建议的研究对于确定其可接受性、可用性和有效性至关重要。
To propose a set of internationally harmonized procedures and methods for assessing neurocognitive functions, smell, taste, mental, and psychosocial health, and other factors in adults formally diagnosed with COVID-19 (confirmed SARS-CoV-2+ WHO definition). We formed an international and cross-disciplinary NeuroCOVID Neuropsychology Taskforce in April 2020. Seven criteria were used to guide the selection of the recommendations’ methods and procedures: (i) Relevance to all COVID-19 illness stages and longitudinal study design; (ii) Standard, cross-culturally valid or widely available instruments; (iii) Coverage of both direct and indirect causes of COVID-19-associated neurological and psychiatric symptoms, (iv) Control of factors specifically pertinent to COVID-19 that may affect neuropsychological performance; (v) Flexibility of administration (telehealth, computerized, remote/online, face to face); (vi) Harmonization for facilitating international research; (vii) Ease of translation to clinical practice. The three proposed levels of harmonization include a screening strategy with telehealth option, a medium size computerized assessment with online/remote option, and a comprehensive evaluation with flexible administration. The context in which each harmonization level might be used is described. Issues of assessment timelines, guidance for home/remote assessment to support data fidelity and telehealth considerations, cross-cultural adequacy, norms and impairment definitions are also described. The proposed recommendations provide rationale and methodological guidance for neuropsychological research studies and clinical assessment in adults with COVID-19. We expect that the use of the recommendations will facilitate data harmonization and global research. Research implementing the recommendations will be crucial to determine their acceptability, usability and validity.